All-in-one milling platforms: How to reduce your machinery footprint
The pharmaceutical industry is currently experiencing a surge in novel drug candidates. These new drug approvals are leading to a…
All articles by Fi Forrest
Fi Forrest
Senior writer at GMS, GlobalData. Previously feature writer at Just Style. TABBIE Honourable Mention winner. BA (Open) in English | BSc (Hons) in Geosciences. Also a graphic designer with certificates in Digital Marketing and Social Media. Lives by the beach.
-
-
Huawei’s top 10 construction principles for intelligent computing centre facilities
Data centres are experiencing significant growth and transformation, driven by the demands of AI model training and deployment, which require…
-
The fundamentals of developing parenteral drug products
A target product profile (TPP) is a set of necessary attributes that the final drug product must have for the…
-
How hybrid models and tech are shaping the future of clinical research
The world of clinical trials is undergoing a rapid change. Today, the rise of decentralized clinical trials (DCTs) and hybrid…
-
Switching from tablets: the benefits of using softgels
Softgels are traditionally thought of in the world of vitamin supplements, but increasingly they are being considered to deliver over-the-counter…
-
Pancreatic cancer: The clinical trial landscape and progress for 2024
Pancreatic cancer is an extremely aggressive disease that forms in the tissues of the pancreas, which plays a crucial role…
-
Oesophageal cancer: the global clinical trials landscape in 2024
Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer mortality. The disease starts in…
-
Secondary packaging for sterile injectables: Overcoming today’s design challenges
The market for injectables is surging, with autoinjectors growing due to their convenience in allowing patients to self-administer medication instead…
-
Overcoming common challenges in fill/finish for monoclonal antibodies (mAbs)
Monoclonal antibodies (or mAbs) are a class of therapeutic proteins designed to target specific molecules or cells in the body.…
-
Safety first: Cognition as a primary safety endpoint provides a competitive advantage
In the evolving landscape of clinical research, the incorporation of cognition into the safety profiles of both CNS and non-CNS…